| Latest | F'cast | |
|---|---|---|
| Div Yield | 2.8% | 0.0% |
| Div Cover | 2.6 | 2.1 |
| Op Mrgn | 22.0% | 26.0% |
| ROCE | 27.5% |
| Latest | F'cast | |
|---|---|---|
| P/E | 13.5 | 20.8 |
| PEG | 0.5 | 1.7 |
| Pr/Revenue | 4.7 | 5.4 |
| Pr/Book | 3.4 |
| Latest | F'cast | |
|---|---|---|
| Revenue | 16.5% | 3.6% |
| PBT | 43.6% | 17.1% |
| EPS | 24.8% | -22.4% |
| DPS | 24.0% | -2.7% |
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-21 | 27.90 | (2.10) | 0.55p | 73.8 | n/a | n/a | n/a | 0.0% |
| 31-Dec-22 | 31.30 | 10.50 | 2.73p | 13.4 | 0.0 | +396% | n/a | 0.0% |
| 31-Dec-23 | 36.80 | 4.10 | 3.87p | 17.3 | 0.4 | +42% | n/a | 0.0% |
| 31-Dec-24 | 41.80 | 7.80 | 3.23p | 19.5 | n/a | -16% | 1.25p | 2.0% |
| 31-Dec-25 | 48.70 | 11.20 | 4.03p | 16.5 | 0.7 | +25% | 1.55p | 2.3% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-26 | 50.45 | 13.11 | 3.13p | 19.5 | n/a | -22% | 1.51p | 0.0% |
| 31-Dec-27 | 54.90 | 14.98 | 3.55p | 17.2 | 1.3 | +14% | 1.77p | 0.0% |
Copyright © 2026 FactSet Research Systems Inc. All rights reserved.
| Total Voting Rights | 01-Jun-2026 | 13:51 | RNS |
| Director/PDMR Shareholding | 29-May-2026 | 15:57 | RNS |
| Result of AGM | 21-May-2026 | 14:47 | RNS |
| Niox trading in line with expectations | 21-May-2026 | ShareCast |
| Niox tops full-year expectations for revenue, ea... | 20-Jan-2026 | ShareCast |
| Total Voting Rights | 31-Dec-2025 | ShareCast |
| Circassia raises £200m in landmark biotech IPO | 14-Mar-2014 | The Independent |
| Cat allergy group raises £200m in float | 14-Mar-2014 | Telegraph |
| Traded | Action | Notifier | Price | Amount | Value |
|---|---|---|---|---|---|
| 29-May-26 | Buy | Sarah Duncan | 58.60p | 34,127 | £19,998.42 |
| 29-May-26 | Sell | Sarah Duncan | 59.00p | 33,916 | £20,010.44 |
| 28-May-26 | Buy | Sarah Duncan | 58.50p | 34,139 | £19,971.31 |
| Currency | UK Pounds |
| Share Price | 61.00p |
| Change Today | 0.000p |
| % Change | 0.00 % |
| 52 Week High | 76.00 |
| 52 Week Low | 54.40 |
| Volume | 49,384 |
| Shares Issued | 420.87m |
| Market Cap | £256.73m |
| Beta | 0.00 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income |
|
|---|
| Growth |
|
|---|
| Strong Buy | 3 |
| Buy | 2 |
| Neutral | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 5 |

| Latest | Previous | |
|---|---|---|
| Final | Final | |
| Ex-Div | 21-May-26 | 15-May-25 |
| Paid | 22-Jun-26 | 16-Jun-25 |
| Amount | 1.55p | 1.25p |
| Time | Volume / Share Price |
| 11:12 | 9,299 @ 60.92p |
| 11:12 | 9,299 @ 60.60p |
| 10:24 | 4,319 @ 61.00p |
| 10:17 | 50 @ 62.80p |
| 09:51 | 32 @ 62.80p |
You are here: research